Loading data
CLPSNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 172.21 m USD | 164.48 m USD | 142.81 m USD | 150.36 m USD | 152.02 m USD |
| Cost of revenue | 141.53 m USD | 128.18 m USD | 109.87 m USD | 115.87 m USD | 111.03 m USD |
| Gross profit | 30.68 m USD | 36.31 m USD | 32.95 m USD | 34.48 m USD | 40.99 m USD |
| Research and development expense | 6.67 m USD | 5.82 m USD | 7.16 m USD | 8.34 m USD | 7.97 m USD |
| Operating profit | -11.46 m USD | -5.38 m USD | -2.54 m USD | 76.39 k USD | 7.41 m USD |
| Income tax expense | 216.94 k USD | 947.53 k USD | 160.73 k USD | 674.34 k USD | 3.05 m USD |
| Net income (reported basis) | -13.18 m USD | -7.05 m USD | -2.33 m USD | 192.53 k USD | 4.46 m USD |
| Net income attributable to common shareholders | -13.18 m USD | -7.05 m USD | -2.33 m USD | 192.53 k USD | 4.46 m USD |
| Basic earnings per share | -0.45 USD/share | -0.26 USD/share | -0.09 USD/share | 0.01 USD/share | 0.21 USD/share |
| Diluted earnings per share | -0.45 USD/share | -0.26 USD/share | -0.09 USD/share | 0.01 USD/share | 0.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.